DiaSorin

Italian biotechnoloty company

DSRNY OTC ISIN IT0003492391 LEI 8156002878BDF0EE4348
Follow DiaSorin Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 EUR · IFRS
Revenue, last year €1.2B +0.8% vs prior year
Net income €155.6M −17.3% vs prior year
EPS, diluted €2.85 −14.9% vs prior year
Operating cash flow €342.8M −4.5% vs prior year
Revenue by fiscal year
€881.3M
€1.2B
€1.4B
€1.1B
€1.2B
€1.2B
FY20 FY21 FY22 FY23 FY24 FY25

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income6 fiscal years
  • Revenue
  • Net income
€0€500M€1B€1.5BFY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€1.2B€155.6M
FY24€1.2B€188.1M
FY23€1.1B€159.8M
FY22€1.4B€240.9M
FY21€1.2B€311M
FY20€881.3M€247.9M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%80%FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2564.7%19.1%13%
FY2465.9%21.8%15.9%
FY2364.6%18.8%13.9%
FY2266.2%25.8%17.7%
FY2166.6%33.9%25.1%
FY2068.4%36.8%28.1%
Free cash flowOperating cash flow minus capital expenditure
€0€100M€200M€300M€400MFY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25€281M
FY24€306.7M
FY23€266.2M
FY22€336.1M
FY21€332.2M
FY20€262.1M
Returned to shareholdersDividends paid and shares bought back
€0€20M€40M€60M€80MFY20FY21FY22FY23FY24FY25
Show the numbers
YearDividends
FY25€63.5M
FY24€61.3M
FY23€59M
FY22€57.1M
FY21€54.7M
FY20€52.1M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • DiaSorin
  • Healthcare median
−100%−50%0%50%FY20FY21FY22FY23FY24FY25
Show the numbers
YearDiaSorinHealthcare median
FY2513%−30.6%
FY2415.9%−47%
FY2313.9%−58%
FY2217.7%−80.4%
FY2125.1%−71.9%
FY2028.1%−62.2%